HomeNewsBusinessEconomyUnfortunately, WTO could not respond with alacrity to control COVID-19 pandemic: Piyush Goyal
Trending Topics

Unfortunately, WTO could not respond with alacrity to control COVID-19 pandemic: Piyush Goyal

Piyush Goyal said that the member countries of the World Trade Organisation (WTO) have let down the people of the LDCs (least developed countries) and developing nations.

June 13, 2022 / 07:07 IST
Story continues below Advertisement
Union Commerce Minister Piyush Goyal
Union Commerce Minister Piyush Goyal

India ramped up its supplies of medical products to different countries to deal with the COVID-19 pandemic, but the WTO could not react with alacrity and the members need to bow their heads in "shame" for their inability to respond in time, Commerce and Industry Minister Piyush Goyal said on Sunday here.

He said that the member countries of the World Trade Organisation (WTO) have let down the people of the LDCs (least developed countries) and developing nations.

Story continues below Advertisement

"My country ramped up supplies of medical products to provide medical and health items globally. Unfortunately, the WTO could not respond with alacrity. We have let down the people of the LDCs and developing countries. The rich countries need to introspect! We need to bow our heads in shame for our inability to respond to the pandemic in time," he said.

Goyal is leading the Indian delegation for the 12th Ministerial Conference (MC) of the WTO. MC is the highest decision-making body of the WTO, and it is meeting after a gap of over four years. The meeting is being held in the backdrop of the Ukraine-Russia war and the global food and energy crisis.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show